Eli Lilly & Co. Earnings Dividend

Eli Lilly & Co.’s revenue jumped 55.55% since last year same period to $19799Mn in the Q1 2026. On a quarterly growth basis, Eli Lilly & Co. has generated 2.63% jump in its revenue since last 3-months.

Eli Lilly & Co.’s net profit jumped 168.04% since last year same period to $7396Mn in the Q1 2026. On a quarterly growth basis, Eli Lilly & Co. has generated 11.45% jump in its net profits since last 3-months.

Eli Lilly & Co.’s net profit margin jumped 72.32% since last year same period to 37.36% in the Q1 2026. On a quarterly growth basis, Eli Lilly & Co. has generated 8.6% jump in its net profit margins since last 3-months.

Eli Lilly & Co.’s price-to-earnings ratio after this Q1 2026 earnings stands at 41.19.

Eli Lilly & Co.’s earning per share (EPS) estimates for the current quarter stand at 8.81 - a 29.75% jump from last quarter’s estimates.

Eli Lilly & Co.’s earning per share (EPS) estimates for the current year stand at 8.81.

Eli Lilly & Co.’s earning per share (EPS) jumped 179.41% since last year same period to 8.55 in the Q1 2026. This indicates that the Eli Lilly & Co. has generated 179.41% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Eli Lilly & Co.’s return on assets (ROA) stands at 0.21.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Eli Lilly & Co.’s return on equity (ROE) stands at 1.07.

Eli Lilly & Co. declared 1.73 dividend per share during the earnings announcement for Q1 2026.